| Full text | |
| Author(s): |
Souza, Ana C. O.
;
Amaral, Andre C.
Total Authors: 2
|
| Document type: | Review article |
| Source: | FRONTIERS IN MICROBIOLOGY; v. 8, MAR 7 2017. |
| Web of Science Citations: | 9 |
| Abstract | |
Fungal diseases have been emerging as an important public health problem worldwide with the increase in host predisposition factors due to immunological dysregulations, immunosuppressive and/or anticancer therapy. Antifungal therapy for systemic mycosis is limited, most of times expensive and causes important toxic effects. Nanotechnology has become an interesting strategy to improve efficacy of traditional antifungal drugs, which allows lower toxicity, better biodistribution, and drug targeting, with promising results in vitro and in vivo. In this review, we provide a discussion about conventional antifungal and nanoantifungal therapies for systemic mycosis. (AU) | |
| FAPESP's process: | 15/10390-6 - IDENTIFICATION OF PATHOGENIC AND CELL DEATH MECHANISMS DURING INFECTION BY P. brasiliensis AND P. lutzii |
| Grantee: | Ana Camila Oliveira Souza |
| Support Opportunities: | Scholarships in Brazil - Post-Doctoral |